Tag Archives: biotechnology law

Takeaways from Chisum’s Washington, D.C. September 2015 Seminar

Posted on October 14, 2015 by Warren Woessner

On September 24-25, 2015, the Chisum Patent Academy held a two-day seminar at the offices of Kaye Scholer LLP in Washington, DC to discuss and debate current developments in U.S. patent law. The roundtable seminar group was limited to ten … Continue reading →

Posted in Conferences and Classes, Miscellaneous, People | Tagged , , , , , , | Leave a comment

Janice Mueller’s New Article: Patent -Ineligible Methods of Treatment

Posted on October 12, 2015 by Warren Woessner

Patent-Ineligible Methods of Treatment Janice M. Mueller  Chisum Patent Academy October 3, 2015 Janice M. Mueller, Patent-Ineligible Methods of Treatment, in MUELLER ON PATENT LAW, VOL. I (PATENTABILITY AND VALIDITY) (Wolters Kluwer Law & Business 2012), last revised October 2015 … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | 1 Comment

USPTO Report on State of Confirmatory Genetic Testing Comes off the Waffle Iron

Posted on October 12, 2015 by Warren Woessner

In 2011—after the Fed. Cir. decision in Myriad upholding claims to BRACA1 and 2 genes—the PTO was tasked by a section of the AIA with providing Congress with a report on the effect of patenting on confirmatory genetic testing. The … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Physiology/Medicine Nobels Awarded for Discoveries of “Natural Products”

Posted on October 8, 2015 by Warren Woessner

In re Roslin Institute, a Fed. Cir. panel consisting of Judges Dyk, Moore and Wallach ruled that clones including Dolly the sheep were not patent eligible. Judge Dyk, writing for the panel endorsed the “markedly different” structure requirement for patent eligibility … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 1 Comment